AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

ARTHROGENIC ALPHAVIRUS VACCINE

Summary

Vaccine comprising live attenuated recombinant alphavirus vaccine comprising mutated capsid protein

Technology Benefits

Vaccine to prevent alphavirus infections such as Chikungunya and Ross River Fever.

Technology Application

Vaccine - disease prevention

Detailed Technology Description

This invention relates to a vaccine comprising live attenuated recombinant alphavirus comprising mutated capsid protein as well as a method for preventing a subject from contracting an alphaviral infection that would otherwise produce clinical signs of disease. In an embodiment that mutated capsid protein is Chikungunya virus capsid protein having mutated nucleolar localisation signal/sequence.

Type of Cooperation

Licensing

Application Date

25/05/2017 00:00:00

Application No.

PCT/AU2017/050489

Country/Region

USA

For more information, please click Here